Chemical Diversity
Chemical Diversity (ChemDiv) is a fully integrated Contract research organization/CRO headquartered in San Diego, California/CA, with subsidiaries in Russia and Ukraine. It provides pharmaceutical and biotech companies integrated discovery and development solutions for their R&D programs. ChemDiv's services cover a range of disciplines needed to bring a new project in CNS, oncology, inflammation, metabolism/metabolic, Infectious disease/infectious and other diseases from identification of a biological target (protein expression, assay development etc.) to clinical drug candidates (ADME/DMPK, toxicity and safety studies, efficacy models etc.) to Proof of Concept drug candidate (Phase I and II) and to the market.
ChemDiv started in 1990 as a chemistry provider and has moved to a full service Contract research organization/CRO since. Among its partners are Eli Lilly[1], Novartis, Dendreon, Merck KGaA, Solvay Pharmaceutical, Bayer, etc.